In vitro evaluation and in vivo performance of lyophilized gliclazide

References

• Palmer KJ, Brogden RN. Gliclazide, an update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus. Drugs 1993;46:92–125
   PubMed Web of Science ®Google Scholar
• Park JY, Kim KA, Kim SL, Park PW. Quantification of gliclazide by semi micro HPLC: application to a bioequivalence study of 2 formulations in healthy subjects. J Pharm Biom Anal 2004;35:943–9
   PubMed Web of Science ®Google Scholar
• Chalk JB, Patterson M, Smith MT, Eadie MJ. Correlations between in vitro dissolution, in vivo bioavailability and hypoglycaemic effect of oral glibenclamide. Eur J Clin Pharmacol 1986;31:77–182
   Web of Science ®Google Scholar
• Blume H, Ali SL, Siewert M. Pharmaceutical quality of glibenclamide products: a multinational postmarket comparative study. Drug Dev Ind Pharm 1993;19:2713–41
   Web of Science ®Google Scholar
• Dressman LJ. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47–60
   PubMed Web of Science ®Google Scholar
• Modi A, Tayade P. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS PharmSciTech 2006;7:E1–E6
   PubMedGoogle Scholar
• Chono S, Takeda E, Seki T, Morimoto K. Enhancement of the dissolution rate and gastrointestinal absorption of pranlukast as a model poorly water-soluble drug by grinding with gelatin. Int J Pharm 2008;347:71–8
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Singh PN, Mishra B. Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin-hydroxypropylmethylcellulose complexes. Pharmazie 2002;57:191–3
   PubMed Web of Science ®Google Scholar
• Sharma GS, Srikanth MV, Sunil SA, et al. Dissolution rate enhancement of poorly soluble gliclazide by complexation with hydroxy propyl Β cyclodextrin. RJPBCS 2011;2:814–23
   Google Scholar
• Garg T. An approach for improvement of the water solubility of gliclazide in solid dispersion with polyethylene glycol 4000. IJPSR 2011;2:1600–2
   Google Scholar
• Shavi1 GV, Kumar AR, Usha1 YN, et al. Enhanced dissolution and bioavailability of gliclazide using solid dispersion techniques. Int J Drug Deliv 2010;2:49–57
   Google Scholar
• Bandarkar FS, Khattab IS. Lyophilized gliclazide-poloxamere solid dispersions for enhancement of in-vitro dissolution and in-vivo bioavailability. Int J Pharm Pharm Sci 2011;3:122–7
   Google Scholar
• Lakshman JP, Cao Y, Kowalski J, Serajuddin AT. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug. Mol Pharm 2008;5:994–1002
   PubMed Web of Science ®Google Scholar
• Alhalaweh A, Andersson S, Velaga SP. Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery. Eur J Pharm Sci 2009;38:206–14
   PubMed Web of Science ®Google Scholar
• Margulis-Goshen K, Magdassi S. Formation of simvastatin nanoparticles from microemulsion. Nanomedicine 2009;5:274–81
   PubMed Web of Science ®Google Scholar
• Strydom S, Liebenberg W, Yu L, de Villiers M. The effect of temperature and moisture on the amorphous-to-crystalline transformation of stavudine. Int J Pharm 2009;379:2–81
   Google Scholar
• Kang Y, Yin G, Ouyang P, et al. Preparation of PLLA/PLGA microparticles using solution enhanced dispersion by supercritical fluids (SEDS). J Colloid Interface Sci 2008;322:87–94
   PubMed Web of Science ®Google Scholar
• Német Z, Sztatisz J, Demeter A. Polymorph transitions of bicalutamide: a remarkable example of mechanical activation. J Pharm Sci 2008;97:3222–32
   PubMed Web of Science ®Google Scholar
• Patterson JE, James MB, Forster AH, et al. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds. J Pharm Sci 2005;94:1998–2012
   PubMed Web of Science ®Google Scholar
• Sonar PA, Behera AL, Banerjee SK, et al. Preparation and characterization of Simvastatin solid dispersion using skimmed milk. Drug Dev Ind Pharm 2013. [Epub ahead of print]. doi:10.3109/03639045.2013.845836
   Google Scholar
• Mollmann SH, Bukrinsky JT, Elofsson U, et al. The stability of insulin in solid formulations containing melezitose and starch. Effects of processing and excipients. Drug Dev Ind Pharm 2006;32:765–78
   PubMed Web of Science ®Google Scholar
• Zhang ZL, Le Y, Wang JX, Chen JF. Preparation of stable micron-sized crystalline irbesartan particles for the enhancement of dissolution rate. Drug Dev Ind Pharm 2011;37:1357–64
   PubMed Web of Science ®Google Scholar
• T Higuchi, KA. Connors, Phase-solubility techniques. Adv Anal Chem Inst 1965;4:117–22
   Google Scholar
• Shah VP, Tsong Y, Sathe P, Liu J. In vitro dissolution profile comparison-statistics and analysis of the similarity factor, f2. Pharm Res 1998;15:889–96
   PubMed Web of Science ®Google Scholar
• Rouini M, Mohajer A, Tahami M. A simple and sensitive HPLC method for determination of gliclazide in human serum. J Chromatogr 2003;785:383–6
   Web of Science ®Google Scholar
• Barakat NS, Elbagory IM, Almurshedi AS. Formulation, release characteristics and bioavailability study of oral monolithic matrix tablets containing carbamazepine. AAPS PharmSciTech 2008;9:931–8
   PubMed Web of Science ®Google Scholar
• Hawe A, Frieβ W. Impact of freezing procedure and annealing on the physico-chemical properties and the formation of mannitol hydrate in mannitol-sucrose-NaCl formulations. Eur J Pharm Biopharm 2006;64:316–25
   PubMed Web of Science ®Google Scholar
• Patel AR, Joshi VY. Evaluation of SLS: APG mixed surfactant systems as carrier for solid dispersion. AAPS PharmSciTech 2008;9:580–93
   Google Scholar
• Juppo AM, Boissier C, Khoo C. Evaluation of solid dispersion particles prepared with SEDS. Int J Pharm 2003;250:385–401
   PubMed Web of Science ®Google Scholar
• Biswal S, Sahoo J, Murthy PN. Physicochemical properties of solid dispersions of gliclazide in polyvinylpyrrolidone K90. AAPS PharmSciTech 2009;10:329–34
   PubMed Web of Science ®Google Scholar
• Kadoya S, Izutsu K, Yonemochi E, et al. Glass-state amorphous salt solids formed by freeze-drying of amines and hydroxyl carboxylic acids: effect of hydrogen-bonding and electrostatic interactions. Chem Pharm Bull 2008;56:821–6
   PubMed Web of Science ®Google Scholar
• Aly UF. Enhancement of solubility and dissolution of atorvastatin calcium: in vitro and in vivo evaluation. Alex J Pharm Sci 2011;25:83–90
   Google Scholar
• Izutsu K, Ocheda SO, Aoyagi N, Kojima S. Effects of sodium tetraborate and boric acid on nonisothermal mannitol crystallization in frozen solutions and freeze-dried solids. Int J Pharm 2004;273:85–93
   PubMed Web of Science ®Google Scholar
• Juppo AM, Boissier C, Khoo C. Evaluation of solid dispersion particles prepared with SEDS. Int J Pharm 2003;250:385–401
   PubMed Web of Science ®Google Scholar
• Shah P, Jogani V, Mishra P, et al. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers. J Pharm Sci 2007;27:10–22
   Google Scholar
• Canfield PE, Geerdes AM, Molitoris BA. Effect of reversible ATP depletion on tight junction integrity in LLC-PK1 cells. Am J Physiol 1991;261:1038–45
   PubMed Web of Science ®Google Scholar